Recent acquisitions by two significant molecular diagnostics players in the bioinformatics space highlight its increasing importance, according to Goldman Sachs analyst Isaac Ro.
Next-generation genome sequencing leader Illumina has agreed to buy privately-held NextBio (Santa Clara, California) for an undisclosed fee
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?